257 related articles for article (PubMed ID: 24717976)
1. Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma.
Caruso D; Abbiati F; Giatti S; Romano S; Fusco L; Cavaletti G; Melcangi RC
J Steroid Biochem Mol Biol; 2015 Feb; 146():74-9. PubMed ID: 24717976
[TBL] [Abstract][Full Text] [Related]
2. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
Melcangi RC; Caruso D; Abbiati F; Giatti S; Calabrese D; Piazza F; Cavaletti G
J Sex Med; 2013 Oct; 10(10):2598-603. PubMed ID: 23890183
[TBL] [Abstract][Full Text] [Related]
3. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients.
Melcangi RC; Santi D; Spezzano R; Grimoldi M; Tabacchi T; Fusco ML; Diviccaro S; Giatti S; Carrà G; Caruso D; Simoni M; Cavaletti G
J Steroid Biochem Mol Biol; 2017 Jul; 171():229-235. PubMed ID: 28408350
[TBL] [Abstract][Full Text] [Related]
4. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
Caruso D; Melis M; Fenu G; Giatti S; Romano S; Grimoldi M; Crippa D; Marrosu MG; Cavaletti G; Melcangi RC
J Neurochem; 2014 Aug; 130(4):591-7. PubMed ID: 24766130
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
Basaria S; Jasuja R; Huang G; Wharton W; Pan H; Pencina K; Li Z; Travison TG; Bhawan J; Gonthier R; Labrie F; Dury AY; Serra C; Papazian A; O'Leary M; Amr S; Storer TW; Stern E; Bhasin S
J Clin Endocrinol Metab; 2016 Dec; 101(12):4669-4680. PubMed ID: 27662439
[TBL] [Abstract][Full Text] [Related]
7. A new look at the 5alpha-reductase inhibitor finasteride.
Finn DA; Beadles-Bohling AS; Beckley EH; Ford MM; Gililland KR; Gorin-Meyer RE; Wiren KM
CNS Drug Rev; 2006; 12(1):53-76. PubMed ID: 16834758
[TBL] [Abstract][Full Text] [Related]
8. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period.
Gilbert Evans SE; Ross LE; Sellers EM; Purdy RH; Romach MK
Gynecol Endocrinol; 2005 Nov; 21(5):268-79. PubMed ID: 16373246
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.
Irwig MS
J Clin Psychiatry; 2012 Sep; 73(9):1220-3. PubMed ID: 22939118
[TBL] [Abstract][Full Text] [Related]
10. Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain.
Giatti S; Foglio B; Romano S; Pesaresi M; Panzica G; Garcia-Segura LM; Caruso D; Melcangi RC
Neuroendocrinology; 2016; 103(6):746-57. PubMed ID: 26646518
[TBL] [Abstract][Full Text] [Related]
11. The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids.
Dušková M; Hill M; Stárka L
Horm Mol Biol Clin Investig; 2010 Jan; 1(2):95-102. PubMed ID: 25961975
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis.
Deligiannidis KM; Kroll-Desrosiers AR; Tan Y; Dubuke ML; Shaffer SA
Psychoneuroendocrinology; 2020 Nov; 121():104827. PubMed ID: 32828068
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum.
Porcu P; O'Buckley TK; Alward SE; Marx CE; Shampine LJ; Girdler SS; Morrow AL
Steroids; 2009; 74(4-5):463-73. PubMed ID: 19171160
[TBL] [Abstract][Full Text] [Related]
14. Finasteride treatment and neuroactive steroid formation.
Dusková M; Hill M; Hanus M; Matousková M; Stárka L
Prague Med Rep; 2009; 110(3):222-30. PubMed ID: 19655698
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
[TBL] [Abstract][Full Text] [Related]
16. Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.
Melcangi RC; Giatti S; Calabrese D; Pesaresi M; Cermenati G; Mitro N; Viviani B; Garcia-Segura LM; Caruso D
Prog Neurobiol; 2014 Feb; 113():56-69. PubMed ID: 23958466
[TBL] [Abstract][Full Text] [Related]
17. Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study.
Melcangi RC; Casarini L; Marino M; Santi D; Sperduti S; Giatti S; Diviccaro S; Grimoldi M; Caruso D; Cavaletti G; Simoni M
Endocr Connect; 2019 Aug; 8(8):1118-1125. PubMed ID: 31272082
[TBL] [Abstract][Full Text] [Related]
18. Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry.
Kim YS; Zhang H; Kim HY
Anal Biochem; 2000 Jan; 277(2):187-95. PubMed ID: 10625505
[TBL] [Abstract][Full Text] [Related]
19. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia.
Irwig MS
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):248-53. PubMed ID: 25871957
[TBL] [Abstract][Full Text] [Related]
20. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile.
Girdler SS; Lindgren M; Porcu P; Rubinow DR; Johnson JL; Morrow AL
Psychoneuroendocrinology; 2012 Apr; 37(4):543-53. PubMed ID: 21890277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
